NLRP3 and myocardial ischemia: This was consistent with the finding of Dai et al., who reported that the exosome-delivered miR-148a alleviated myocardial ischemia/reperfusion injury by abrogating the TXNIP-mediated activation of the NLRP3 inflammasome [38].